Search research articles
Contact Us
Filters
Showing results (221-230 of 339) with videos related to
Page
of 34
Sort By:
Annals of the Rheumatic Diseases
|
January 29, 2017
Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study
Désirée van der Heijde, Atul Deodhar, James C Wei, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 8, 2025
Long-term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the clarity AD open-label extension study
Christopher H van Dyck, Reisa Sperling, Keith Johnson, et al.
Frontiers in Psychiatry
|
January 2, 2023
IL-17 and TNF-β: Predictive biomarkers for transition to psychosis in ultra-high risk individuals
Lijun Ouyang, David Li, Zongchang Li, et al.
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC
|
April 15, 2016
Expected health benefits of e-Therapeutics Highlights according to pharmacists and physicians
Pierre Pluye, Araceli Gonzalez-Reyes, David Li Tang, et al.
Journal for Immunotherapy of Cancer
|
December 18, 2024
Adenoviral-vectored neoantigen vaccine augments hyperexpanded CD8<sup>+</sup> T cell control of tumor challenge in mice
Gabriel Dagotto, Alessandro Colarusso, Robert C Patio, et al.
Plos Genetics
|
December 14, 2021
TM2D genes regulate Notch signaling and neuronal function in Drosophila
Jose L Salazar, Sheng-An Yang, Yong Qi Lin, et al.
Journal of the American Chemical Society
|
June 28, 2019
Chemical Proteomic Profiling of Bromodomains Enables the Wide-Spectrum Evaluation of Bromodomain Inhibitors in Living Cells
Xin Li, Yizhe Wu, Gaofei Tian, et al.
Bioorganic & Medicinal Chemistry
|
July 13, 2007
Novel 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 agonists and antagonists
Hassan Elokdah, David Li, Geraldine McFarlane, et al.
Elife
|
November 5, 2014
Identification of 'erasers' for lysine crotonylated histone marks using a chemical proteomics approach
Xiucong Bao, Yi Wang, Xin Li, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 24, 2011
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
Douglas S Goodin, Anthony Traboulsee, Volker Knappertz, et al.
Page
of 34
Search research articles
Search
Showing results (221-230 of 339) with videos related to
Sort By:
Page
of 34
Annals of the Rheumatic Diseases
|
January 29, 2017
Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study
Désirée van der Heijde, Atul Deodhar, James C Wei, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 8, 2025
Long-term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the clarity AD open-label extension study
Christopher H van Dyck, Reisa Sperling, Keith Johnson, et al.
Frontiers in Psychiatry
|
January 2, 2023
IL-17 and TNF-β: Predictive biomarkers for transition to psychosis in ultra-high risk individuals
Lijun Ouyang, David Li, Zongchang Li, et al.
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC
|
April 15, 2016
Expected health benefits of e-Therapeutics Highlights according to pharmacists and physicians
Pierre Pluye, Araceli Gonzalez-Reyes, David Li Tang, et al.
Journal for Immunotherapy of Cancer
|
December 18, 2024
Adenoviral-vectored neoantigen vaccine augments hyperexpanded CD8<sup>+</sup> T cell control of tumor challenge in mice
Gabriel Dagotto, Alessandro Colarusso, Robert C Patio, et al.
Plos Genetics
|
December 14, 2021
TM2D genes regulate Notch signaling and neuronal function in Drosophila
Jose L Salazar, Sheng-An Yang, Yong Qi Lin, et al.
Journal of the American Chemical Society
|
June 28, 2019
Chemical Proteomic Profiling of Bromodomains Enables the Wide-Spectrum Evaluation of Bromodomain Inhibitors in Living Cells
Xin Li, Yizhe Wu, Gaofei Tian, et al.
Bioorganic & Medicinal Chemistry
|
July 13, 2007
Novel 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 agonists and antagonists
Hassan Elokdah, David Li, Geraldine McFarlane, et al.
Elife
|
November 5, 2014
Identification of 'erasers' for lysine crotonylated histone marks using a chemical proteomics approach
Xiucong Bao, Yi Wang, Xin Li, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 24, 2011
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
Douglas S Goodin, Anthony Traboulsee, Volker Knappertz, et al.
Page
of 34